Aegerion - Mary Szela
Last July, Aegerion pharmaceuticals said goodbye to its controversial CEO Marc Beer and appointed board member Sandford Drexel Smith as its interim leader.
Last week, the firm announced Mary Szela, the former CEO of Melinta Therapeutics, would lead Aegerion going forward.
“With two marketed products, orphan drug development expertise and a growing global footprint, I believe we have the potential to build a sustainable company and make a meaningful impact on the lives of patients," added Ms. Szela.
“I'm truly excited to join Aegerion's dedicated team of employees and directors as we advance the Company's mission to deliver break-through medicines for rare diseases.”
